Chief Medical Officer of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Baldo Lance, sells 2,000 shares worth $89,000
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 16 09:00 PM, company Chief Medical Officer, Baldo Lance disclosed selling 2,000 shares at a cost of $44.50. At the time of this transaction (Apr 14), this trade was worth $89,000 in total. As of Apr 14, Baldo Lance now owns 22,894 shares in total worth about $962,234.8200000001.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) Chief Medical Officer, Baldo Lance, we have the following information:
- SEC Form 4 filing: Jan 27: Sold 40,000 shares at the rate of $58.95 per share. Total worth of this trade was $2,358,117. Total number of shares owned as of Jan 27 were 0
- SEC Form 4 filing: Dec 07: Sold 6,250 shares at the rate of $50.41 per share. Total worth of this trade was $315,088. Total number of shares owned as of Dec 07 were 0
- SEC Form 4 filing: Nov 06: Sold 6,250 shares at the rate of $50.63 per share. Total worth of this trade was $316,449. Total number of shares owned as of Nov 06 were 0
Posted by
George Daniels
on Saturday April 17 2021, 3:45 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
